Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraise and appointment of sole broker

26 Mar 2018 07:00

RNS Number : 8391I
Sabien Technology Group PLC
26 March 2018
 

FOR IMMEDIATE RELEASE

26 March 2018

Sabien Technology Group plc

 ("Sabien" or the "Company")

 

GBP400,000 Fundraise at Premium

Appointment of Sole Broker

Director's Dealings

Total Voting Rights

 

 

Sabien Technology Group plc is pleased to announce that Peterhouse Corporate Finance Limited has raised gross proceeds of £400,000 via the placing of 80,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.5 pence (the "Placing Price") per Placing Share (the "Placing"). The Placing has been completed at a 25 per cent. premium to the closing mid-market price on 22 March 2018 of 0.4 pence.

 

Appointment of Broker

 

Sabien is also pleased to announce that it has appointed Peterhouse Corporate Finance Limited as Sole Broker to the Company, effective immediately.

 

Admission of the Placing Shares

 

Once issued, the Placing shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Placing Shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will become effective on or around 29 March 2018.

 

Director's Participation

 

A Director has agreed to subscribe for Placing Shares in the Placing at the Placing Price as per the table below (the "Director's Participation"):

 

 

Director

Number of Ordinary Shares pursuant to Placing

Beneficial shareholding following Placing

Percentage of Ordinary Shares as enlarged by the Placing

Bruce Gordon - Chairman

14,768,479

44,768,479

23.54%

 

B. Gordon is also a director of Thames Valley Capital Limited, an advisor to TVI 2 Limited, which holds 4,108,356 ordinary shares in the Company. He is therefore interested, directly and indirectly, in 48,876,835 Ordinary shares, representing 25.69% of the enlarged issued share capital.

 

The Director's Participation as set out above ("the Transaction") is a related party transaction under the AIM Rules. The Directors, independent of the Transaction, consider, having consulted with the Company's Nominated Adviser, that the terms of the Transaction are fair and reasonable so far as shareholders of the Company are concerned.

 

 

 

 

Total Voting Rights

 

Following Admission, there will be 190,254,867 Ordinary Shares in issue. The figure of 190,254,867 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Sabien under the Disclosure and Transparency Rules.

 

The following information relating to the transaction has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation,

 

Bruce Gordon

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Bruce Gordon

 

2

Reason for notification

a)

Position / status

Chairman

 

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sabien Technology Group plc

 

b)

LEI

213800S5QG1SMGHFHY68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each in Sabien Technology Group plc

 

 

GB00B1FPCD38

 

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

0.4pence

14,768,479

 

 

d)

Aggregated information

n/a

e)

Date of the transaction

23 March 2018

f)

Place of the transaction

LSE, AIM (XLON)

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information: 

Sabien Technology Group plc

+44(0)20 7993 3700

 

Alan O'Brien

 

 

Beaumont Cornish Limited (Nominated Advisor)

 +44(0)20 7628 3396

 

Michael Cornish and Roland Cornish

www.beaumontcornish.com

 

 

Peterhouse Corporate Finance Limited (Sole Broker)+44 (0) 20 7469 0930

Martin Lampshire and Fungai Ndoro

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZFKKVGRZM
Date   Source Headline
12th Oct 20227:00 amRNSHolding(s) in Company
5th Oct 20223:33 pmRNSHolding(s) in Company
23rd Sep 20222:49 pmRNSHolding(s) in Company
20th Sep 20224:16 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSRevised Date for Summit for S'th Korean Delegation
31st Aug 20225:00 pmRNSTotal Voting Rights
25th Aug 20223:30 pmRNSAdmission to trading of new Ordinary Shares
22nd Aug 20226:24 pmRNSResult of General Meeting
19th Aug 20227:00 amRNSSales Channel Partnership
16th Aug 20227:00 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSExtension of Sales Agency Agreement
5th Aug 20225:15 pmRNSNotice of GM & Holdings in the Company
4th Aug 20227:00 amRNSOversubscribed Broker Option to raise £100,000
3rd Aug 20227:00 amRNSPlacing to raise £500,000 & Broker Option
8th Jul 202212:45 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update
7th Jun 20227:00 amRNSHolding(s) in Company
13th May 20227:00 amRNSWelsh Freeport
5th May 20227:00 amRNSUpdate on b.grn
11th Apr 20221:00 pmRNSCorporate Update - Contract Win
4th Apr 20225:00 pmRNSProject COFFEE - Replacement
4th Apr 20222:30 pmRNSProject COFFEE
31st Mar 20224:02 pmRNSHalf-year Report
31st Mar 20227:00 amRNSHolding(s) in Company
25th Mar 20227:00 amRNSContract Win
3rd Feb 20222:03 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSMOU signed with Irish Renewable Fuels Ltd.
1st Feb 20222:43 pmRNSLicence agreement with Proton Technologies Canada
18th Jan 20227:00 amRNSChanges to Warrant Terms
14th Jan 20224:25 pmRNSHolding(s) in Company
31st Dec 202112:00 pmRNSTotal Voting Rights
22nd Dec 20217:00 amRNSAgreement for Establishment of SPV
26th Nov 20217:00 amRNSWarrant Exercise
11th Nov 20217:00 amRNSLicence agreement with Proton Technologies
4th Nov 20217:00 amRNSRole of Carbon Credits, Blockchain & Carbon Market
1st Nov 20217:00 amRNSCOP26: Sabien hosts Green Economics Debate
29th Oct 20215:00 pmRNSTotal Voting Rights
14th Oct 20213:00 pmRNSResult of AGM
14th Oct 202110:00 amRNSSabien Presentation at FTE Mykonos
14th Oct 20218:00 amRNSIssue of Equity
14th Oct 20217:30 amRNSAGM Statement
14th Oct 20217:00 amRNSSubscription and possible Co-operation Agreement
21st Sep 20217:00 amRNSHolding(s) in Company
16th Sep 20211:02 pmRNSAeristech: Investor Update
16th Sep 202111:30 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSSales Agency Agreement
14th Sep 20216:00 pmRNSPosting of Annual Report & Notice of AGM
31st Aug 20217:12 amRNSFinal Results for the year to 30 June 2021
31st Aug 20217:00 amRNSFinal Results for the Year to 30 June 2021
10th Aug 202112:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.